18
Participants
Start Date
August 25, 2022
Primary Completion Date
December 25, 2023
Study Completion Date
December 25, 2026
Anti-CEA CAR-T Cells
"The study will evaluate the safety of intravenous infusion of anti-CEA CAR-T (+) cells in humans at doses of 1×10\^6/kg, 3×10\^6/kg, and 6×10\^6/kg using a standard 3+3 design and preliminarily observe the efficacy."
RECRUITING
Department of Colorectal Surgery in Changhai Hospital, Shanghai
Changhai Hospital
OTHER